Save time and cost with plexWell. Contact us today!
0

plexWell™ Plasmid Sequencing
& Assembly

High-Throughput plexWell™ Plasmid Sequencing and
De Novo Assembly Service

Our plexWellTM Pro service with de novo assembly, specially optimized for plasmids.

As demonstrated in our Plasmid Sequencing Application Note, the plexWell platform offers a streamlined workflow, flexible reagent configurations, and more data from less sequencing. This has enabled the seqWell team to develop a high-quality, high-throughput service for complete plasmid sequencing and de novo assembly. Turnaround time is typically two weeks from sample reception.

Unique Service Features:

  • Simple sample submission in 96 well PCR plates
  • Cost-effective, high-throughput sequencing
  • 1 Gbase of data per 96 samples
  • De-novo assembly via custom analysis pipeline; no reference required
  • Fast turnaround time (typically within 2 weeks of sample reception)

Data Delivery Features:

  • Secure web-based delivery through AWS
  • Sample Identification by plate name and well position
    • Paired FASTQ files 
    • FASTA files for assembled samples

plexWell plasmid assembly example

Talk to our services team about your project.

To maximize customer value, output and quality, we provide a custom quote for every customer. Contact sales to get started.

Plasmid Sequencing & Assembly Resources

Sample Submission Requirements

Sample Submission Form

Scalable, true multiplexed library preparation enables high-performance, high-throughput plasmid sequencing

PW096

plexWell™ Safety Notice

seqWell’s products and services are intended for Research Use Only, not for diagnostic or clinical purposes. seqWell does not accept DNA samples derived from known or suspected pathogens, infectious agents, or any sample type that could present a significant biohazard risk to couriers, our employees, our community, or the environment. Also, federal laws and international regulations apply to the shipping and handling of certain types of biological specimens. If your sample is potentially bio-hazardous, you must first inquire with a competent regulatory authority for guidance and to ensure compliance with this safety notice, and then contact seqWell before placing an order.
Caught in the Act: Tracking the Emergence and Divergence of SARS-CoV-2 through Statewide Testing and SequencingUPCOMING WEBINAR

Date:  March 23, 2022
Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEDT)

Learning Objectives

  • Understand the utility of full-genome viral sequence analysis for public health
  • Recognize how viral load impacts the ability to detect and sequence intact SARS-CoV-2
  • Identify the similarities and differences in host responses to SARS-CoV-2 depending on strain and immunologic history

Speakers

Frank A. Middleton, Ph.D.
Professor Director, SUNY Molecular Analysis CoreState University of New York (SUNY) Upstate Medical University

Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer of seqWell Inc.

REGISTER NOW